Poster overview per track

All the posters will be on display from Monday 1 May to Thursday 4 May.

Poster presenters will be asked to be standing by their poster to answer questions from Conference delegates from 16:00 – 17:00 hrs on either Monday 1 May, Tuesday 2 May or Wednesday 3 May.

Which day will depend on the topic of the poster:
Monday 1 May: Track A
Tuesday 2 May: Track B
Wednesday 3 May: Track C and Track D

Your poster board number is the abstract code shown below.

 

Poster Presentation Track A

Monday 1 May

A-OP-001 Laura Gibson Community Engagement to Improve Prevention and Treatment of Congenital Cytomegalovirus Infection
A-OP-002 Marjolein Korndewal Cost of illness of congenital CMV infection
A-OP-003 Katrin Neumann First outcomes of an international project on a universal neonatal screening for congenital CMV infections
A-OP-004 Shannon Ross Characteristics and Hearing Outcomes of Symptomatic Congenital CMV Infection: Findings from the CHIMES Study
A-OP-005 Aparecida Yulie Yamamoto Neuroimaging findings as potential predictors of adverse outcomes in asymptomatic congenital CMV infection (cCMV) identified at birth
A-OP-006 Albert Park Outcomes From a State-wde Hearing-Targeted Cytomegalovirus Screening Program
A-OP-007 Michiel Van Boven Infectious Reactivation of Cytomegalovirus Explaining Age- and Sex-Specific Patterns of Seroprevalence
A-OP-008 Karen Fowler Increasing Awareness and Promoting Strategies for Prevention of Congenital Cytomegalovirus Infection (cCMV) Among Young Pregnant Women
A-PP-001 Efraim Bilavsky Characteristics of newborns born with congenital cytomegalovirus infection after multiple-birth pregnancy
A-PP-002 Tatiana Lanzieri Cytomegalovirus Seroprevalence among Children 1-5 Years of Age in the United States
A-PP-003 Marisa M Mussi-Pinhata Cytomegalovirus (CMV) shedding in seropositive pregnant women from a high seroprevalence population (BRACHS Study)
A-PP-004 Sebastian Voigt Cytomegalovirus reactivation in pediatric acute leukemia after stem cell transplantation has an effect on relapse and survival in AML
A-PP-005 Chengbin Wang Urinary Cytomegalovirus Shedding in the United States: the National Health and Nutrition Examination Surveys, 1999-2004
A-PP-006 Chengbin Wang Viral Loads of Different Specimens in Congenital Cytomegalovirus Infection from Highly Immune Population
A-PP-007 Marianne Leruez-Ville Risks factors for congenital CMV following primary and non-primary maternal infection: a prospective neonatal screening study using PCR in saliva
A-PP-008 Dimitra Dimopoulou Factors influencing the outcome of infants with congenital CMV Infection
A-PP-009 Mattia Russel Pantalone A CMV-like virus is implicated in head and neck paraganglioma, a highly vascular tumor of the autonomic nervous system
A-PP-010 Vlasta Stepanova Study of Cytomegalovirus Seroprevalence in the Czech Republic Population
A-PP-011 Sara Doutre Losing Ground: Awareness of Congenital Cytomegalovirus in the United States
A-PP-012 Sara Doutre Raising Awareness of Congenital CMV through Legislative Advocacy: The Expansion of CMV Laws in the United States
A-PP-013 Wendy Van Zuijlen Congenital CMV in audiology clinics and childcare - opportunities for diagnosis and prevention using existing resources
A-PP-014 Laura Puhakka Congenital CMV infection in Finland – a prospective cohort study
A-PP-015 Aparecida Yulie Yamamoto Congenital human herpesvirus 6 (HHV-6) infection: birth prevalence, persistence and frequency of viral variants in saliva.
A-PP-016 Gerhard Jahn Outcome of HCMV Non-Primary Infection in Pregnancy: Incoming Data from China and Implication on the View in the Scientific Community
A-PP-017 Kassiani Kekkou Risk of Cytomegalovirus transmission with IgG avidity in the grey zone during pregnancy and the impact of Hyperimmune Globulin treatment
A-PP-018 Jos Van Acker Contamination and peculiar cases during a congenital cytomegalovirus neonatal screening program: a plea for decentralized screening
A-PP-019 Josine In 't Veld Congenital CMV infection and the occurrence of cystic periventricular leukomalacia
A-PP-020 Karen Fowler Degree and Audiometric Patterns of Cytomegalovirus-Related Sensorineural Hearing Loss in Children: Findings from the CHIMES Study
A-PP-021 Karen Fowler Cytomegalovirus Seropositivity and Adverse Pregnancy Outcomes in an Urban Cohort
A-PP-022 Emmanouela Dimitrakopoulou Challenges of a universal newborn screening for congenital cytomegalovirus infections by saliva specimens
A-PP-023 Cecilia Söderberg-Naucler Human Cytomegalovirus can Promote Human Colorectal Cancer through reduced EphB2 Expression
A-PP-024 Sophie Alain Congenital CMV survey in general population in France
A-PP-025 Petr Hubacek Detection of CMV in urine and mother’s milk samples among the babies in neonatal ICU in Motol University Hospital.
A-PP-026 Wim Soede Infants diagnosed with congenital CMV after NHS refer: a variety of signs in infected infants without clinical signs at birth
A-PP-027 Chengbin Wang Prevalence of Cytomegalovirus Strains in the United States: the National Health and Nutrition Examination Surveys, 1999-2004
     

Poster Presentation Track B

Tuesday 2 May

B-OP-001 Ravit Boger Role of cytoplasmic receptors NOD1 and NOD2 in CMV control
B-OP-002 Valentina Dell'Oste The Human Cytomegalovirus tegument protein pp65 (pUL83) dampens interferon-type I production by inactivating the DNA sensor cGAS
B-OP-003 Laura Hertel Human cytomegalovirus genome replication is inhibited in mature Langerhans-type dendritic cells.
B-OP-004 M. Zeeshan Chaudhry CMV abrogates CD8 T-cell control by inhibiting apoptosis, not by inhibiting antigen presentation
B-OP-005 Anke Redeker The contribution of CMV infection to immune senescence is set by the initial viral inoculum
B-OP-006 Selmir Avdic Simultaneous analysis by mass cytometry (CyTOF) of impact of human cytomegalovirus-encoded homologs of hIL-10 on multiple cellular signalling pathways
B-OP-007 Edward Mocarski Cytomegalovirus-encoded Death Suppressors Cooperate to Prevent Proinflammatory Consequences of Combined Apoptosis and Necroptosis.
B-OP-008 Niels Lemmermann Mast cells as rapid innate sensors of cytomegalovirus by TLR3/TRIF signaling-dependent and -independent mechanisms
B-OP-009 Paulo Martins Cytomegalovirus reactivation in bone marrow transplantation:  is controlling graft-versus-host disease important?
B-OP-010 Sofia Caldeira-Dantas Infection of the salivary gland by MCMV is dispensable for formation and persistence of salivary gland CD8+ TRM
B-OP-011 Emma Poole Changes in the total cell proteome during human cytomegalovirus  latency - insights into effects on latently infected monocytes
B-OP-012 Cornelia Pokalyuk HCMV reinfection in congenitally infected infants: an evolutionary perspective
B-OP-013 Ceri Fielding Control of immune ligands by members of the cytomegalovirus US12 gene family suppresses  natural killer cell activation
B-OP-014 Lenore Pereira Lessons from an epidemic: Patterns of Cytomegalovirus and Zika virus infection modeled in the human placenta ex vivo
B-OP-015 Michael McVoy A clinical CMV isolate passaged on fibroblasts in the presence of hyperimmuneglobulin retains epithelial tropism and an intact UL128-131A locus
B-OP-016 Emmanuel Wiertz CRISPR/Cas9-mediated genome editing of human cytomegalovirus limits productive infection
B-OP-017 Stéphane Chavanas Human cytomegalovirus infection enhances the expression of genes critical for neural cell migration in neural stem cells and fetal brain
B-OP-018 K. Yeon Choi A New Strain of Guinea Pig CMV Suggests a More Prudent Strategy for Evaluation of Interventions Against Congenital CMV
B-OP-019 Steffanie Sabbaj Breast milk HCMV viral load drives the establishment of breast milk CMV-pp65-specific CD8 T cells in HCMV infected mothers.
B-OP-020 Klaus Frueh The UL40 homologue Rh67 is required for the induction of MHC-E-restricted CD8+ T cells by RhCMV
B-OP-021 Masany Jung The endothelin B receptor is critical for human cytomegalovirus infection in endothelial cells and a potential target for anti-viral therapy
B-OP-022 Chris Benedict Late-rising CD4 T cells resolve CMV persistence
B-OP-023 Richard Stanton In Wildtype HCMV, the Pentameric Complex Drives Efficient Direct Cell-Cell Transmission that is Resistant to Host Immune Defenses
B-PP-001 Miguel López-Botet Adaptive NKG2C+ NK cell response and the risk of cytomegalovirus infection in kidney transplant recipients
B-PP-002 Nico Contreras The role of anti-Cytomegalovirus CD8 T cell responses in adipose metabolic dysregulation and diabetes.
B-PP-003 Anna Luganini US16 Protein of Human Cytomegalovirus Contributes to Virus Tropism for Endothelial and Epithelial Cells by Regulating  Virion Pentameric Complex Content
B-PP-004 Elizabeth Elder US28-induced changes in host factors during HCMV latency
B-PP-005 Albert Park Excessive Reactive Oxygen Species and Murine CMV Labyrinthitis: A Possible Target for Therapy?
B-PP-006 Laura Hertel Maturation of Langerhans-type dendritic cells alters human cytomegalovirus gene expression, progeny production and reactivation from latency in a stimulus-dependent manner.
B-PP-007 Ian Humphreys Interferon-induced transmembrane protein 3 prevents cytokine-driven cytomegalovirus pathogenesis
B-PP-008 Melanie Brinkmann The antiviral cGAS-STING-mediated type I interferon response to murine cytomegalovirus  (MCMV) is inhibited by the multifaceted MCMV m152 membrane protein
B-PP-009 Layal Massara Impact of HCMV on native and modified HLA-I and consequences on gamma delta T cells activation
B-PP-010 William Chang High rhesus cytomegalovirus shedding frequency is associated with Th2-biased CD4 and attenuated CD8 T-cell responses following subcutaneous challenge
B-PP-011 Sarah Elizabeth Jackson High latent viral loads in CD14+ monocytes associates with increased breadth and frequency of IFNγ secreting CMV specific T cells
B-PP-012 Ester Remmerswaal Functional separation of IL7Ra/KLRG1-defined CD8+ T cell populations in humans
B-PP-013 Bodo Plachter Subcellular localization of pp65 is a critical determinant for human cytomegalovirus productivity
B-PP-014 M. Zeeshan Chaudhry Conserved death-receptor signaling inhibition identified by a chimeric mouse CMV expressing a homologous human CMV gene
B-PP-015 Huanhuan Leah Cui L-proline promotes human Cytomegalovirus replication via activation of DNA Damage Response Pathways
B-PP-016 George Sedikides CD4 and CD8 T cell responses to human cytomegalovirus proteins expressed by latently infected cells
B-PP-017 Ourania N. Kostopoulou Targeting Pol I through CX5461, a specific Pol I inhibitor, or Pol I siRNA, affects HCMV transcription, not virus production
B-PP-018 Tian Shu Fan The oncomodulatory role of HCMV-encoded chemokine receptor US28 in glioblastoma
B-PP-019 Thomas Stamminger Inhibitors of the autophagy-initiating protein kinase Ulk1 interfere with HCMV replication
B-PP-020 Amna Malik CMV specific CD8+ T cell responses in African children and adults
B-PP-021 Roberta Rovito The role of HLA-C, HLA-E and HLA-G in the long-term outcome of congenital Cytomegalovirus infection
B-PP-022 Melissa Broeks B cell Phenotyping Before Renal Transplantation Associated With Cytomegalovirus Infection, But Not With Biopsy Proven Acute Rejection
B-PP-023 Irene Goerzer Differences in growth properties among two human cytomegalovirus glycoprotein O genotypes
B-PP-024 Ganna Galitska Genotypic analysis of HCMV polymorphism in congenital infections to predict the impact of HCMV disease severity in newborns/infants
B-PP-025 Amitinder Kaur Pre-infection infusion of hyperimmune globulin (HIG) can protect rhesus macaques against congenital CMV transmission
B-PP-026 Eddie Chung Yern Wang Human Cytomegalovirus UL148 downregulates CD58 and demonstrates co-stimulation for CD8+ CTL against HCMV-, but not uninfected, targets
B-PP-027 Sara Pautasso The DNA Cytosine Deaminase APOBEC3G is upregulated during Human Cytomegalovirus infection
B-PP-028 Yiska Weisblum Studies of innate-immune responses in the maternal-fetal interface reveal distinct mechanisms of defense against congenital HCMV and ZIKV infections
B-PP-029 Yujuan Yue Insights into the pathogenesis of wild-type rhesus cytomegalovirus strains upon multiple oral mucosa inoculations
B-PP-030 David Vermijlen Human foetal hematopoietic stem and progenitor cells (HSPC) generate invariant HCMV-reactive ?d T cells
B-PP-031 Juliet Spencer The HCMV US27 gene product targets transcription factor NRF-1 to upregulate CXCR4
B-PP-032 Andrew Davison Genomic analysis of chimeric human cytomegalovirus vaccine candidates derived from strains Towne and Toledo
B-PP-033 G. Clement Dobbins Next Generation Sequencing of CMV Genomes from Congenitally Infected Infants Identifies Variants Associated with Newborn disease and CMV-related Hearing Loss
B-PP-034 Hannes Vietzen HCMV- specific Antibody Mediated NK- cell Activation and Neutralization in Lung Transplant Recipients
B-PP-035 Jeffrey van Senten The constitutively active HCMV-encoded G protein-coupled receptor UL33 displays oncomodulatory potential
B-PP-036 Cornelia Pokalyuk About the impact of reinfection and persistence in host-pathogen systems subject to balancing selection
B-PP-037 Masaya Takemoto Induction of chemokines and chemokine receptors of glioblastoma infected with human cytomegalovirus
B-PP-038 Martina Schneider A modified protein in situ hybridization method allows screening of genetic variants of glycoprotein B AD4 mutants for its immunogenicity
B-PP-039 Eva Maria Borst United we stand, divided we falter: mutual dependence of HCMV terminase subunits pUL51, pUL56, and pUL89 for terminase complex formation
B-PP-040 Yu Jiun Chan Human Cytomegalovirus Infected Colorectal Cancer Cell Lines Increase the Cell Proliferation and Migration Activities
B-PP-041 Sara P.H. Van den Berg Characterization of immunological reaction to CMV in super healthy elderly
B-PP-042 Anita Van der Zwan Are maternal HCMV-specific CD8+ T cells at the maternal-fetal interface able to  cross-react with fetal HLA-C?
B-PP-043 Hester Nichols Characterisation of Human Cytomegalovirus US12 gene family-encoded proteins
B-PP-044 Chiara Fornara Human cytomegalovirus-specific memory T-cell response and its correlation with virus transmission to the fetus in pregnant women with primary infection
B-PP-045 Diana Vera Cruz Influence of maternal hyperimmune globulin (HIG) infusion on viral diversity and congenital transmission
B-PP-046 Helena Costa Cytomegalovirus downregulates ER-a, PR and Her-2 Receptors in Breast Cancer -A potential role in triple negative breast cancer?
B-PP-047 Carmen Bedford RL13 and the UL128 Locus co-operate in promoting direct cell-to-cell transmission of human cytomegalovirus.
B-PP-048 Michael McVoy Polymorphisms in human cytomegalovirus gO may confer escape from neutralization by antibodies targeting epitopes in gH/gL
B-PP-049 Fenyong Liu Human cytomegalovirus UL23 inhibits transcription of interferon-? stimulated genes and blocks antiviral interferon-? responses by interacting with N-myc interactor protein
B-PP-050 Laura Gibson Viral Effective Population Size and Selection Coefficient Reveal Disease Status and Treatment Outcome
B-PP-051 Liliana Gabrielli Hyperechogenic bowel and congenital CMV infected fetuses
B-PP-052 Mark Schleiss Neonatal CMV infection-induced learning disabilities and impaired neurocognitive performance in the Morris Water Maze associated with CD4+/CD8+ neuroinflammatory infiltrates
B-PP-053 Elizabeth Swanson Cytomegalovirus (CMV) Transmission by Breast Milk: Establishment of a Small Animal Model
B-PP-054 Sophie Alain Variability of gB UL55 from whole genome sequencing of congenital isolates
B-PP-055 K. Yeon Choi Guinea Pig CMV pp65 or pp71 Null Mutants have Opposite Phenotypes to Each Other in Tissue Culture and in Animals
B-PP-056 Alistair McGregor Evaluation of guinea pig CMV (GPCMV) IE1 and IE2 as Functional HCMV Homologs and Potential Vaccine T cell target antigens
B-PP-057 Alistair McGregor UL128 Homolog Mutants Form Pentameric Complexes but Recombinant Viruses have Attenuated Cell Tropism and Pathogenicity in the Guinea Pig Model
B-PP-058 Cathy Yea Won Sung CMV in the Developing Mouse Cochlea and Hearing Loss
     

Poster Presentation Track C & Track D

Wednesday 3 May

     
C-OP-001 Nicolás Suárez Challenges and opportunities in sequencing complete human cytomegalovirus genomes directly from clinical material
C-OP-002 Anne Rascle Clinical validation of T-Track® CMV to assess the functionality of CMV-specific cell-mediated immunity in kidney transplant recipients
C-OP-003 Concetta Marsico CYTOMEGALOVIRUS-SPECIFIC CD8+ T-CELL IMMUNITY IN NEONATES WITH CONGENITAL INFECTION: CORRELATION WITH CLINICAL AND LABORATORY FINDINGS
C-OP-004 Alina Huth Analysis of T cells targeting human cytomegalovirus by Next Generation Sequencing
C-OP-005 Tiziana Lazzarotto Interaction between soluble HLA-G expression and HCMV infection during pregnancy
C-OP-006 Joppe Nijman Neurodevelopmental outcome and hearing in early childhood of preterm infants with postnatal cytomegalovirus infection
D-OP-001 Mark Schleiss Live-CMV vaccines lacking viral MHC I homologs are attenuated in guinea pigs but confer sterilizing immunity against congenital CMV transmission
D-OP-002 Tong-Ming Fu Active evolution of memory B-cells specific for viral gH/gL/pUL128-131 pentameric complex in healthy subjects with silent human cytomegalovirus infection
D-OP-003 Eleni Panagioti The breadth of synthetic long peptide vaccine-induced CD8+ T cell responses determines the efficacy against mouse cytomegalovirus infection
D-OP-004 Stuart Hamilton Novel antivirals for the prevention and treatment of congenital CMV
D-OP-005 Anders Lilja A CMV vaccine based on non-replicating lymphocytic choriomeningitis virus vectors expressing gB and pp65 is safe and immunogenic in man
D-OP-006 Nicolle Litjens CMV-specific CD4+ T cells in CMV-IgG-seronegative individuals protect from CMV viremia following transplantation with a CMV-seropositive donor kidney
D-OP-007 Tihana Trsan KLRG1+ CD8 T cells induced by cytomegalovirus vector expressing NKG2D ligand RAE-1γ provide robust protection against tumor challenge
D-OP-008 Alistair McGregor Disabled Infectious Single Cycle (DISC) Cytomegalovirus Vaccine Encoding Pentameric Complex is Completely Protective Against Congenital Guinea Pig CMV
CD-PP-001 Eleni Panagioti Enforced OX40 stimulation empowers booster vaccines to stimulate protective CD4+ and CD8+ T cell responses against cytomegalovirus infection
CD-PP-002 Tatiana Lanzieri Trends in valganciclovir use among infants with congenital cytomegalovirus infection in the United States, 2009-2014
CD-PP-003 Sunwen Chou A third component of the human cytomegalovirus terminase complex is involved in letermovir resistance
CD-PP-004 Jie Ying Jacklyn Neo Developing fully human monoclonal antibodies as candidate therapeutics for HCMV infection
CD-PP-005 Tsugiya Murayama Inhibitory effect of tricin on CCL2-CCR2 dependent human cytomegalovirus replication
CD-PP-006 Maurizio Zavattoni Cytomegalovirus-related polymicrogyria in seroimmune pregnant women
CD-PP-007 Verena Kuret A rare case of periconceptional congenital cytomegalovirus infection in a dichorionic twin pregnancy
CD-PP-008 Clemens Joos CMV-specific T cells through retroviral transduction of gammadelta T cells for adoptive T cell transfer
CD-PP-009 Anne Rascle Functional impairment of CMV-reactive cellular immunity during pregnancy
CD-PP-010 Catharina Matheï CMV screening during pregnancy in Belgium: the gap between theory and practice.
CD-PP-011 Ilona Anna Baraniak Characterization of epitope-specific humoral responses to human cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in solid organ transplant recipients
CD-PP-012 Angela Chiereghin Evaluation of cytomegalovirus-specific cell-mediated immunity in heart transplant recipients by two different Enzyme-linked ImmunoSPOT (EliSpot) assays
CD-PP-013 Justen Hoffman Russell Expression of Simian Immunodeficiency Virus (SIV) Antigens by Bacterial Artificial Chromosome (BAC)-Derived Infectious Cynomolgus Macaque CMV (CyCMV)
CD-PP-014 Mark Schleiss Prospective monitoring for CMV DNAemia in VLBW infants identifies unrecognized but clinically significant breast milk-acquired infections in high-risk NICU patients
CD-PP-015 Wendy Van Zuijlen Human cytomegalovirus alters expression of Wnt receptor ROR2 and migration of infected trophoblasts in an autocrine manner
CD-PP-016 Moriuchi Masako Usefulness of Viral Load Measurement and Therapeutic Drug Monitoring in the Treatment of Infants with Cytomegalovirus Disease
CD-PP-017 Suzanne Luck Prevention of congenital CMV through hygiene-based behavioural interventions: A review of the literature and gap analysis
CD-PP-018 Martine Smit Nanobodies targeting oncomodulatory CMV-encoded chemokine receptors as potential diagnostics and therapeutics
CD-PP-019 Zsolt Ruzsics Construction of replication competent high capacity vectors based on murine cytomegalovirus
CD-PP-020 Elena Costa Association between Cytomegalovirus (CMV) viral load in fetal blood and antenatal  imaging  anomalies
CD-PP-021 Horst Buxmann Congenital Cytomegalovirus saliva screening triggered by repeated failure on newborn hearing screening – a pilot study
CD-PP-022 Afsar Rahbar Significant association between Human Cytomegalovirus-IEA and expression of cyclooxygenase-2 and 5-lipoxygenase in human breast cancer specimens
CD-PP-023 Afsar Rahbar Ovarian Cancer Survival is Associated  with detection of Human cytomegalovirus infection in the tumor
CD-PP-024 David E Anderson Enveloped Virus-like Particle (eVLP) Delivery of an Optimized Form of Glycoprotein B for Prophylactic Vaccination Against Congenital Cytomegalovirus
CD-PP-025 Afsar Rahbar High prevalence of cytomegalovirus infection in surgical intestinal specimens from infants with necrotizing enterocolitis and spontaneous intestinal perforation
CD-PP-026 Matthias Stefan Schampera Influence of HCMV pentameric complex-specific depletion on neutralizing capacity of immunoglobulin preparations
CD-PP-027 Cody Nelson Glycoprotein B subunit immunization elicits limited IgG responses against defined gB neutralizing epitopes
CD-PP-028 Sara Ornaghi Valnoctamide reverses CMV-mediated brain injuries and neurological deficits in newborn mice
CD-PP-029 Graciela Andrei Experience of a translational research platform for the evaluation of HCMV drug-resistance in Belgium
CD-PP-030 Manfred Marschall Combined biochemical and in silico-structural analyses of cytomegalovirus kinase pUL97 to specify the targeting of inhibitory small molecules
CD-PP-031 Elizaveta Padalko Comparison of culture from urine and PCR after 2 different extraction methods from DBS in clinically suspected for cCMV neonates
CD-PP-032 Giulia Piccirilli Cytomegalovirus infection and antiviral drug resistance in hematopoietic stem cell transplant recipients
CD-PP-033 Anne Sauer Effects of letermovir and Bay 38-4766 on human cytomegalovirus DNA cleavage and packaging
CD-PP-034 Sébastien Hantz Comparison of H-DiaCMVQ (Diagenode) and CMV R-gene (Biomérieux) for CMV viral load quantification in whool blood specimens
CD-PP-035 Eva Karltorp Congenital CMV infection gives rise to a complex pattern of difficulties
CD-PP-036 Suzanne Luck Treatment of congenital CMV in Europe:  From Chaos to Collaboration
CD-PP-037 Sophie Alain Brincidofovir resistance during rescue therapy in French transplant recipients
CD-PP-038 Klaus Hamprecht Pharmakokinetics of hyperimmune globulin (HIG) administration for prevention of maternofetal CMV-transmission in primary infected pregnant women
CD-PP-039 Karl Oliver Kagan Effectiveness of a 2 weekly HIG protocol in first trimester CMV infection
CD-PP-040 Ulrika Löfkvist Pragmatic skills and executive functions in  children with congenital cytomegalovirus infection and cochlear implants - a comparative cross-sectional study
CD-PP-041 Klaus Hamprecht Analytical performance of CMV serodiagnosis at birth and in early primary infection
CD-PP-042 Kenji Tanimura The presence of cytomegalovirus-DNA in the uterine cervical secretion is an independent predictor of congenital infection in high-risk pregnant women
CMV 2017: the 6th International congenital CMV conference/16th International CMV/betaherpesvirus workshop in 2017<